COMPLETED

Satisfaction With eMotion in a Diverse Group of Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The eMotion intervention, developed by the PI, provides training on multiple emotion regulation skills based on leading theories and evidence-based emotion regulation interventions. After initial pilot testing of eMotion, the investigators revised the intervention to make it more relevant to women from diverse backgrounds, as these women are disproportionately impacted by social determinants of health that complicate their recovery. It is important to revise the intervention to be acceptable to women from diverse backgrounds and to address their unique needs. The investigators want to explore if women from diverse backgrounds find the revised intervention relevant, meaningful, and easy to understand and apply to their lives. Their feedback will help investigators further revise the intervention to make it acceptable for this population.

Official Title

Satisfaction With eMotion in a Diverse Group of Women

Quick Facts

Study Start:2024-06-05
Study Completion:2024-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06404866

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * First-time major cardiac event as documented in the medical record
  2. * Lives independently
  3. * Has at least mild symptoms of depression (determined by Patient Health Questionnaire-8 \[PHQ-8\] scores of 5 or greater) and/or at least mild symptoms of anxiety (determined by the General Anxiety Disorder \[GAD-7\] scores of 5 or greater).
  1. * Does not understand both spoken and written English
  2. * In palliative care or hospice
  3. * Legally blind

Contacts and Locations

Principal Investigator

Kelly L Wierenga, PhD
PRINCIPAL_INVESTIGATOR
Indiana University School of Medicine

Study Locations (Sites)

Eskenazi Hospital
Indianapolis, Indiana, 46202
United States

Collaborators and Investigators

Sponsor: Indiana University

  • Kelly L Wierenga, PhD, PRINCIPAL_INVESTIGATOR, Indiana University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-05
Study Completion Date2024-10-01

Study Record Updates

Study Start Date2024-06-05
Study Completion Date2024-10-01

Terms related to this study

Keywords Provided by Researchers

  • Emotion Regulation

Additional Relevant MeSH Terms

  • Cardiac Events
  • Emotions